NCT02809365View on ClinicalTrials.gov

FreeStyle Libre- Effect on QOL in Type 2 Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

October 31, 2017

Conditions
Type 2 Diabetes
Interventions
DEVICE

FreeStyle Libre

Addition of FreeStyle Libre system for 10 weeks to the treatment of uncontrolled Type 2 diabetic patients currently on multiple daily injections

DEVICE

personal glucometer

Subjects in the Control Group will measure blood glucose levels by personal glucometer (SMBG = self monitoring blood glucose)

Trial Locations (2)

58100

E. Wolfson Medical Center, Holon

Wolfson Medical Center, Bariatric Surgery Clinic, Holon

All Listed Sponsors
lead

Wolfson Medical Center

OTHER_GOV

NCT02809365 - FreeStyle Libre- Effect on QOL in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter